Nemzeti Élelmiszerlánc-biztonsági Hivatal/National Food Chain Safety Office
Based on the challenges of the common agricultural policy and the demand for a consistent management of professional policy, all the agricultural administrative institutes and departments, were integrated into one institution called Central Agricultural Office (CAO) on 1 January 2007. The CAO as a central office directed by the Minister of Agriculture and Rural Development dealt with the questions related to agricultural managerial activities.
On 15th March 2012 CAO and the former Hungarian Food Safety Office were integrated into a new office establishing the National Food Chain Safety Office (NFCSO). NFCSO operates as a legal successor of the CAO and the HFSO incorporating all aspects of the food chain safety supervision into one single authority.
The Office is directed by the President, the work of whom was assisted by four Vice Presidents responsible for the following fields: Institution Management, Food-Chain Safety, Natural and Genetic Resources, and Economy.
The Directorate of Veterinary Medicinal Products (DVMP) as part of NFCSO is responsible for authorisation and control of veterinary medicinal products in Hungary. The Directorate also represents the Hungarian authority in international bodies (eg: Committees of European Medicines Agency (EMEA), European Directorate for the Quality of Medicines (EDQM)). The Immunological Department prepares assessment reports for authorisation of veterinary vaccines and sera. Control activity of the department consists of test of pre-registration samples, random tests of authorised immunological products and Official Control Authority Batch Release (OCABR). The laboratory of the department is a member of the Official Medicines Control Laboratory Network (EDQM OMCL). The animal facility (in Gödöllő, about 30 km from Budapest) belongs to the Immunological Department. There are 4 conventional stables and a biosafety level-2 animal house in the farm. The BSL-2 animal house was opened in 2006.
The overall aim of this work is to test the different B cell immunogens designed by the consortial partners. Immunogenicity studies are carried out on model small animals (New Zealand White rabbits). The venue of the studies is the biosafety level-2 Animal Facility of Central National Food chain Safety Office, Directorate of Veterinary Medicinal Products (NFCSO-DVMP), which locates in Gödöllő. The use of rabbits as model small animals is justified by the facts that rabbit is one of the most common species currently used to assess HIV antibody response and therefore, data are available for comparison purposes. Another attractive aspect is the relatively large volume of blood with easy access without significant trauma for the animals. Last but not least the veterinary and animals caretaker staff of NFCSO-DVMP is already properly trained on mucosal administration and sampling of rabbits and have vast expertise in small animal handling.http://www.nebih.gov.hu
Gábor Kulcsár is the director of National Food Chain Safety Office, Directorate of Veterinary Medicinal Products; Attila Farsang is a principal investigator at NFCSO being responsible for the research activities of the Directorate.email@example.com